Peter Anevski Insider Information

COO of Progyny

Peter Anevski currently serves as the president and chief operating officer of Progyny Inc. 

Anevski first joined Progyny in 2017 as the company’s executive vice president, COO and chief financial officer, becoming president and COO in September 2020. During his time at Progyny, Anesvski has headed the company’s financial actions, optimized its operations and built up its premier provider network. 

Prior to joining Progyny, Anevski spent over 17 years as the executive vice president and CFO of WebMD, beginning in 1999. During his tenure, Anevski played a major role in improving WebMD’s financial performance. From 1994 to 1999, Anevski worked in corporate accounting for Toys “R” Us. He began his career as a public auditor and CPA with Wiss & Company in 1992. 

Anevski earned his undergraduate degree from Montclair State University and is a member at The American Institute of Certified Public Accountants and the New Jersey State Society of Certified Public Accountants.

What is Peter Anevski's net worth?

The estimated net worth of Peter Anevski is at least $14.75 million as of August 11th, 2022. Mr. Anevski owns 324,916 shares of Progyny stock worth more than $14,751,186 as of August 17th. This net worth estimate does not reflect any other investments that Mr. Anevski may own. Additionally, Mr. Anevski receives an annual salary of $785,770.00 as COO at Progyny. Learn More about Peter Anevski's net worth.

How old is Peter Anevski?

Mr. Anevski is currently 55 years old. There are 3 older executives and no younger executives at Progyny. The oldest executive at Progyny is Mr. David J. Schlanger, Exec. Chairman, who is 63 years old. Learn More on Peter Anevski's age.

What is Peter Anevski's salary?

As the COO of Progyny, Inc., Mr. Anevski earned a total compensation package of $785,770.00 in 2021. Mr. Anevski earned a salary of $425,000.00, non-equity compensation of $350,000.00, and other compensation of $10,770.00.There are 2 executives that earn more than Mr. Anevski. The highest earning executive at Progyny is Mr. Mark S. Livingston, Chief Financial Officer, who commands a salary of $955,470.00 per year. Learn More on Peter Anevski's salary.

How do I contact Peter Anevski?

The corporate mailing address for Mr. Anevski and other Progyny executives is 1359 BROADWAY, NEW YORK NY, 10018. Progyny can also be reached via phone at 212-888-3124 and via email at [email protected] Learn More on Peter Anevski's contact information.

Has Peter Anevski been buying or selling shares of Progyny?

During the past quarter, Peter Anevski has sold $1,381,120.00 in Progyny stock. Most recently, Peter Anevski sold 16,000 shares of the business's stock in a transaction on Thursday, August 11th. The shares were sold at an average price of $44.68, for a transaction totalling $714,880.00. Following the completion of the sale, the chief executive officer now directly owns 324,916 shares of the company's stock, valued at $14,517,246.88. Learn More on Peter Anevski's trading history.

Who are Progyny's active insiders?

Progyny's insider roster includes Peter Anevski (COO), Jennifer Bealer (EVP), Lisa Greenbaum (EVP), Mark Livingston (CEO), Norman Payson (Director), David Schlanger (CEO), and Cheryl Scott (Director). Learn More on Progyny's active insiders.

Are insiders buying or selling shares of Progyny?

In the last twelve months, insiders at the sold shares 70 times. They sold a total of 1,536,518 shares worth more than $76,995,711.18. The most recent insider tranaction occured on August, 11th when CEO Peter Anevski sold 16,000 shares worth more than $714,880.00. Insiders at Progyny own 14.0 % of the company. Learn More about insider trades at Progyny.

Information on this page was last updated on 8/11/2022.

Peter Anevski Insider Trading History at Progyny

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/11/2022Sell16,000$44.68$714,880.00324,916View SEC Filing Icon  
8/9/2022Sell16,000$41.64$666,240.00324,916View SEC Filing Icon  
6/27/2022Sell80$31.21$2,496.80324,916View SEC Filing Icon  
3/4/2022Sell21,000$43.59$915,390.00View SEC Filing Icon  
3/2/2022Sell21,000$44.02$924,420.00View SEC Filing Icon  
2/28/2022Sell125,931$39.09$4,922,642.79View SEC Filing Icon  
2/15/2022Sell17,569$41.39$727,180.91View SEC Filing Icon  
2/11/2022Sell600$42.00$25,200.00View SEC Filing Icon  
1/3/2022Sell21,000$51.17$1,074,570.00View SEC Filing Icon  
10/7/2021Sell27,539$59.53$1,639,396.67View SEC Filing Icon  
10/5/2021Sell27,500$57.98$1,594,450.00View SEC Filing Icon  
9/30/2021Sell88,882$56.72$5,041,387.04View SEC Filing Icon  
9/28/2021Sell55,000$56.86$3,127,300.00View SEC Filing Icon  
8/25/2021Sell63,621$51.74$3,291,750.54View SEC Filing Icon  
6/3/2021Sell21,000$62.49$1,312,290.00499,079View SEC Filing Icon  
6/1/2021Sell21,000$63.99$1,343,790.00499,079View SEC Filing Icon  
5/5/2021Sell21,000$53.21$1,117,410.00583,079View SEC Filing Icon  
5/3/2021Sell21,000$56.18$1,179,780.00583,079View SEC Filing Icon  
4/7/2021Sell200$45.74$9,148.00667,079View SEC Filing Icon  
4/5/2021Sell26,833$46.08$1,236,464.64667,079View SEC Filing Icon  
4/1/2021Sell800$46.19$36,952.00667,079View SEC Filing Icon  
3/10/2021Sell8,999$47.43$426,822.57667,079View SEC Filing Icon  
2/3/2021Sell21,000$47.84$1,004,640.00666,146View SEC Filing Icon  
2/1/2021Sell21,000$47.93$1,006,530.00666,146View SEC Filing Icon  
1/6/2021Sell21,000$43.30$909,300.00666,146View SEC Filing Icon  
1/4/2021Sell21,000$42.47$891,870.00666,146View SEC Filing Icon  
12/3/2020Sell21,000$37.12$779,520.00834,146View SEC Filing Icon  
12/1/2020Sell21,000$35.50$745,500.00834,146View SEC Filing Icon  
11/13/2020Sell12,886$30.95$398,821.70834,146View SEC Filing Icon  
11/11/2020Sell97,503$29.79$2,904,614.37834,146View SEC Filing Icon  
11/9/2020Sell37,454$29.88$1,119,125.52834,146View SEC Filing Icon  
9/29/2020Sell84,000$29.30$2,461,200.00834,146View SEC Filing Icon  
8/28/2020Sell80,000$28.61$2,288,800.00918,146View SEC Filing Icon  
8/17/2020Sell35,000$29.96$1,048,600.001,453,146View SEC Filing Icon  
8/14/2020Sell75,000$29.55$2,216,250.001,453,146View SEC Filing Icon  
8/12/2020Sell11,378$30.06$342,022.681,564,755View SEC Filing Icon  
7/13/2020Sell24,940$27.74$691,835.601,470,579View SEC Filing Icon  
7/10/2020Sell4,444$27.70$123,098.801,470,579View SEC Filing Icon  
5/13/2020Sell84,000$25.06$2,105,040.001,550,135View SEC Filing Icon  
See Full Table

Peter Anevski Buying and Selling Activity at Progyny

This chart shows Peter Anevski's buying and selling at Progyny by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Progyny Company Overview

Progyny logo
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Read More

Today's Range

Now: $45.40
Low: $44.28
High: $45.90

50 Day Range

MA: $32.09
Low: $26.06
High: $46.08

2 Week Range

Now: $45.40
Low: $25.67
High: $68.32


554,062 shs

Average Volume

936,328 shs

Market Capitalization

$4.18 billion

P/E Ratio


Dividend Yield